Healthcare Triangle, Inc.
HCTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $4 | $4 | $2 |
| % Growth | -1.9% | -3.9% | 69.1% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $2 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 17.7% | 13.9% | 8.9% | 11.7% |
| R&D Expenses | $0 | $0 | $0 | -$0 |
| G&A Expenses | $2 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $2 | $1 |
| Sales & Mktg Exp. | -$1 | $1 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $0 | -$0 |
| Operating Expenses | $3 | $2 | $2 | $1 |
| Operating Income | -$3 | -$1 | -$1 | -$0 |
| % Margin | -74.3% | -38.2% | -37.7% | -22.7% |
| Other Income/Exp. Net | $1 | -$0 | -$0 | -$1 |
| Pre-Tax Income | -$2 | -$1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$1 |
| % Margin | -54.6% | -38.4% | -45.9% | -61.6% |
| EPS | -89.92 | -64.54 | -80.2 | -59.23 |
| % Growth | -39.3% | 19.5% | -35.4% | – |
| EPS Diluted | -89.92 | -64.54 | -80.2 | -59.23 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | -$0 |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -51.9% | -37.9% | -34.4% | -29% |